ADIM
THC icon

Alpha DNA Investment Management’s Tenet Healthcare THC Stock Holding History

Alpha DNA Investment Management’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,352
Closed -$423K – 162
2024
Q4 		$423K Buy
3,352
+307
+10% +$45.6K 0.16% 159
2024
Q3 		$506K Buy
+3,045
New +$461K 0.19% 109
2021
Q2 		– Sell
-26
Closed -$1K – 596
2021
Q1 		$1K Buy
+26
New +$1.31K ﹤0.01% 655

Other funds holding THC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Alpha DNA Investment Management's THC Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Tenet Healthcare (THC) in Q1 2025, closing a stake of 3,352 shares — an estimated $423K sold.

Alpha DNA Investment Management first reported a position in THC in Q1 2021 and held it in 3 quarters. The position peaked at $506K in Q3 2024. 566 funds tracked by Wall St. Rank hold THC as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining Tenet Healthcare position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 3,352 Tenet Healthcare shares in Q1 2025, an estimated $423K.
  • Alpha DNA Investment Management first reported a position in Tenet Healthcare in Q1 2021 and held it in 3 quarters.
  • Alpha DNA Investment Management's Tenet Healthcare position peaked at $506K in Q3 2024.
  • 566 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.